The importance of new technologies in cancer treatment: precision oncology — Dr Antonio Giordano
Intervention at early stages can transform tumors in “chronic and manageable diseases”.
Precision oncology is the best weapon for defeating cancer. With the use of new technologies, it is possible to quickly detect genetic variations through gene sequencing: an early discovery of changes in the human body can guide cancer diagnosis and treatment with precision and effectiveness.
Surgical procedures can become faster, time of detection of the health issue shorter, samples for analysis smaller as well as the costs for patients and for the health system. Access to these new therapeutic and diagnostic strategies will soon lead to increasingly personalized and precise analysis and treatments, increasing the chances of patient survival. Moreover, intervening in the initial stages of the disease can really transform cancer in “a chronic and manageable disease”.
Using the most advanced technologies and investing in this sector will give greater push to research and the discovery of early diagnoses. The conversion to digitization, which helps to bridge the gap between doctor and patient in reasonable time, is also essential for quick access to medical exams.
The pandemic had devastating effects on cancer patients, due to the numerous delayed diagnoses. However, thanks to the technologies available, we can live in a world “without the fear of cancer diagnosis”, as mentioned in the World Economic Forum, whose latest work has been focusing on improving and transform cancer-fighting strategies around the world, with special emphasis on poor countries.
Even if in the foreseeable future, the cancer trend is increasing, we have the tools to fight it thanks to personalized treatments that will positively redefine our prospects in the fight against cancer.
If you enjoyed reading this blog and want to explore more about Health, Biological science, cancer research and cancer treatment advancements read my latest blog on — The Human memory is a defence from trauma through removal — by Antonio Giordano
Dr. Antonio Giordano is the President and Founder of the Sbarro Health Research Organization (SHRO) located at Temple University’s College of Science and Technology in Philadelphia, which conducts research to diagnose, treat and cure cancer, cardiovascular disease, diabetes, and other chronic illnesses.
Connect with Dr Giordano on: Facebook, LinkedIn, Twitter, and Instagram to receive regular updates on cancer research, scientific advancements in cancer treatments and organizational information
Also view Dr Giordano’s researches and citations on Google scholar
